Skip to content

Drug interactions

Estradiol + Fezolinetant

Severity: Contraindicated

Estradiol and Fezolinetant: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Estradiol weakly inhibits CYP1A2 and can raise fezolinetant exposure. Higher fezolinetant levels increase the risk of adverse effects including hepatotoxicity, and labeling contraindicates CYP1A2 inhibitors.

What this interaction means in plain words

Estradiol and Fezolinetant are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Estradiol belongs to Endocrine; Fezolinetant belongs to Endocrine.

Evidence level: High

Why it happens

Estrogens inhibit CYP1A2, the main enzyme metabolizing fezolinetant.

What to do

Do not use fezolinetant with estrogen therapy; choose one treatment for vasomotor symptoms. If used, monitor liver tests.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Estradiol and Fezolinetant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Estradiol with Fezolinetant?

MediHelp rates the interaction as contraindicated. Estradiol and Fezolinetant are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Estradiol weakly inhibits CYP1A2 and can raise fezolinetant exposure. Higher fezolinetant levels increase the risk of adverse effects including hepatotoxicity, and labeling contraindicates CYP1A2 inhibitors.

How serious is the interaction between Estradiol and Fezolinetant?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not use fezolinetant with estrogen therapy; choose one treatment for vasomotor symptoms. If used, monitor liver tests.

What other medicines interact with Estradiol?

MediHelp also lists interactions of Estradiol with, for example, Anastrozole, Ospemifene, Antithrombin alfa. The full list is on the Estradiol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in